Elliott Vichinsky, MD

Title(s)Professor, Pediatrics
SchoolSchool of Medicine
Address747 52nd Street, #903D
Oakland CA 94609
Phone510-428-3651
ORCID ORCID Icon0000-0002-0500-9579 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Wisconsin, MadisonB.S. 1970Biology
    State University of New York DownstateM.D.1974School of Medicine
    Children's Orthopedic Hospital and Medical Center, Seattle, WAInternship1975Pediatrics
    Children's Orthopedic Hospital and Medical Center, Seattle, WAFellowship1978Pediatrics
    University of Washington, Seattle, WASenior Research Fellow1979Dept of Pediatrics and Medicine
    Collapse Awards and Honors
    15th Annual Sickle Cell Disease Educational Summit. Cayenne Wellness Center. Sept 13-16 2023. Los An2023Award of Distinction: "Celebrating Sickle Cell's Giants, Pioneers, and Visionaries"
    UCSF Benioff Chilldren’s Hospital2019UCSF Benioff Chilldren’s Hospital Endowed Clinical Care Professorship
    American Society of Pediatric Hematology Oncology (ASPHO)2019Distinguished Career Award
    Sickle Cell Disease Association of America (SCDAA)2013Pioneer Award
    Cooley's Anemia Foundation2009Distinguished Leadership as Chair of the Medical Advisory Board
    Cooley's Anemia Foundation Medical Advisory Board2009Distinguished Leadership Award
    Sickle Cell Disease Foundation of California2007Lifetime Achievement Award
    Sickle Cell Disease Assocation of America (SCDAA) and the NHLBI2007Charles F. Whitten, M.D. Lecture Award
    UCSF Benioff Children's Hospital Oakland2007Grateful Families Award
    Children's Hospital & Research Center Oakland2005Bronze Bambino Lifetime Achievement Award
    Sickle Cell Community Health Network of Northern California2004Patient Commitment Award
    UCSF Benioff Children's Hospital Oakland2003Social Worker's Award
    Thalassemia Action Group2003Patient Appreciation Award
    UCSF Benioff Children's Hospital Oakland2000Scientific Achievement Award
    UCSF Benioff Children's Hospital Oakland1997Senior Scientist Award
    Cooley's Anemia Foundation1996Cooley's Anemia Award
    Children's Miracle Network1995Miracle Maker Award
    Alpha Omega Alpha Honor Society1974Alpha Omega Award
    State University of New York Downstate1974Cum Laude
    University of Wisconsin1970Cum Laude

    Collapse Overview 
    Collapse Overview
    SUMMARY OF INTERESTS:
    Protecting and advancing the health and well-being of children through clinical care, teaching, and research; hematology; hemoglobin, hemoglobin disorders; designing and leading clinical research studies; understanding the pathophysiology of hemoglobinopathies; comprehensive clinical care; evaluating therapeutic interventions to improve disease outcomes; expanding patient access to quality healthcare; improving patient quality of life; health equity; establishing, improving, and expanding networks of care for hemoglobinopathy patients; designing and leading collaborative multi-center trials; forming and leading regional, national, and international collaborative research networks; implementation studies; data collection; registry and surveillance systems for hemoglobinopathies; expanding enrollment in clinical trials; accelerating the pace of clinical research; writing, editing, and reviewing grant applications, abstracts, peer-reviewed manuscripts, chapters, and books; publishing research findings; presenting research findings to diverse audiences; developing, updating, publishing, and teaching standards of care guidelines for optimal management of hemoglobinopathy patients; training and expanding the healthcare workforce knowledgeable in the standard of care treatments; developing and teaching academic curricula; junior and mid-career faculty career development; recruiting and mentoring under-represented faculty in medicine and science; diversity in medicine and research; mentoring others to become leading independent clinician scientists equipped to advance the field; sickle cell disease; sickle cell anemia; sickle cell trait; pain management; acute chest syndrome; avascular necrosis; bone disease; organ failure; priapism; pulmonary hypertension; hemolysis; alloimmunization; iron dysregulation; brain iron; chelation therapy, neurodegeneration; NBIA; PKAN; thalassemia syndromes; alpha thalassemia major; fetal hemoglobin; in utero transfusion, intrauterine stem cell transplantation; Bart's fetalis syndrome; stroke; transcranial doppler; TCD screening; prenatal and newborn screening; genetic counseling; BMT; gene and stem cell therapy; red blood cell biology; laboratory medicine; pheresis medicine; transfusion medicine; global medicine; political advocacy to improve healthcare policy; collaborating with community advisory boards and involving them as part of the research team to ensure our research activities are guided by the needs and concerns of people affected.

    I am an endowed physician and professor in residence at the University of California San Francisco Benioff Children's Hospital in Oakland, California. For nearly 40 years I have been on forefront of research into better treatments and potential cures for hemoglobinopathies. My directorship of the largest and most comprehensive program for individuals with sickle cell disease and their families in the western United States began in 1978. Renamed the UCSF Sickle Cell Center of Excellence and rebuilt stronger, my center continues its mission to improve clinical outcomes and quality of life for individuals living with sickle cell and their families across the lifespan.

    I direct the Hemoglobinopathy Reference Laboratory for the State of California at UCSF Benioff Children's Hospital Oakland, which has been a national resource to aid in the diagnosis of clinically relevant hemoglobinopathies since 1973 (the laboratory has been a vital component of the state's newborn screening follow-up program, evaluating clinically relevant hemoglobin variants, providing confirmatory testing on all newborns in California with presumptive sickle cell disease, beta thalassemia or HbH disease, and assisting NBS programs across the country.

    Throughout my career I have developed successful teams that bring basic and clinical investigators together in partnership with the biomedical and pharmaceutical industry to develop and evaluate new treatments for hemoglobinopathies. I was lead investigator of the safety and efficacy of several important therapies for sickle cell disease, such as arginine, mitapivat, and other promising drug trials. I was the senior/principal author of the drug trials of voxelotor and glutamine and played a pivotal role securing their FDA-approval.

    In addition to leading the development of novel therapeutics, I serve as PI or Co-PI on several key evidence-based clinical research networks, such as the American Society of Hematology’s Research Collaborative (as the Western States Sickle Cell Disease Clinical Trials Network); the NHLBI’s SC-Links study (Linking the Sickle Cell Community, Providers and Systems to Improve Sickle Cell Disease Care (SCDIC); the NHLBI’s REDS-IV-P study (Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric, Domestic Hubs); the Network for California Sickle Cell Care and HRSA’s Pacific Sickle Cell Regional Collaboration, which aims to reduce morbidity and mortality by improving the quality of coordinated and comprehensive services to individuals with sickle cell disease and their families. These networks link together researchers, clinicians, and communities affected by sickle cell disease to guide evidence-based treatment and improve patient care.

    I am commitment to fostering the next generation of translational and clinical scientists and guide the academic development of my colleagues through participation in programs like the American Society of Pediatric Hematology Oncology’s Mid-Career Mentoring Program, the Doris Duke Charitable Foundation’s Clinical Research Mentorship Program, and the NIH’s Mentored Research Scientist Career Development Program (K series). I have supported young students from disadvantaged backgrounds explore potential career opportunities in healthcare and science through my involvement in the UCSF Summer Student Program.

    I am a passionate advocate to improve healthcare policies for people living with sickle cell disease. Over the years I have provided scientific insight and medical expertise to legislators and health care policy makers at the regional, state, and federal levels of government, including my work with California Congresswoman Barbara Lee, State Superintendent of Public Instruction Tony Thurmond, California Assemblymember Mike Gibson, the California State Health Subcommittee, and multiple mayoral leaders of the City of Oakland, California to improve and increase access to comprehensive care for Californians living with sickle cell disease.
    Collapse In The News

    Collapse Research 
    Collapse Research Activities and Funding
    The Pacific Sickle Cell Regional Collaboration (PSCRC)/ Sickle Cell Treatment Demonstration Program (SCTDP)
    HRSA/CIBD U1EMC27862Sep 1, 2021 - Aug 31, 2026
    Role: Co-PI
    Description: CIBD in conjunction with UCSF Benioff Children’s Hospital in Oakland partners with core expert SCD clinicians in 13 states and our trusted partners. To meet HRSA’s priorities, the PSCRC works to enhance the health of individuals with SCD through the following goals: 1. Strengthen systems of care for individuals with SCD and their families by synergizing with the SCD Newborn Screening Follow-Up Program, the SCDTDP regions, and the Hemoglobinopathies National Coordinating Center (HNCC) to facilitate partnerships between clinicians, community organizations and other stakeholders; 2. Improve outcomes for individuals with SCD and their families by developing and strengthening regional and state SCD network infrastructures that includes components necessary for providing comprehensive services; 3. Develop and support comprehensive care teams in seven states to increase access to evidence based care and the latest treatment options, increase collaboration and care coordination, and implement telehealth technologies; 4. Establish and maintain reporting mechanisms to provide data annually.
    Cooperative Agreement to Support Comprehensive Medical Care for Thalassemia
    HRSA U1AMC28548Feb 10, 2020 - May 31, 2026
    Role: Co-Investigator
    Description: The Thalassemia Western Consortium is a regional network of 10 thalassemia treatment centers in the western United States established to develop standards of care for blood transfusions in thalassemia, guidelines for the management of hemoglobin H disease, collect data on thalassemia services and outcomes, and conduct provider outreach/education. GOALS: By May 2026, the provide medical service to at least 420 thalassemia patients; 2) increase transfusion dependent thalassemia patients served by 25%; 3) increase in number of health care providers receiving education or training on evidence-based guidelines for treating thalassemia patients 20%; and 4) increase in number of health care providers who use evidence-informed thalassemia treatment guidelines 25%.
    Networking California for Sickle Cell Care (NCSCC)
    State of California/CIBD CIBDNCSCC2019-UCSF-01Jan 1, 2020 - Jun 30, 2023
    Role: Co-PI
    Description: The NCSCC is a statewide network of healthcare researchers, providers, and community partners whose mission is to improve the health of Californians affected by sickle cell disease (SCD) and sickle cell trait. The initiative will establish 5 new adult SCD centers in the state, which will link outpatient care to inpatient services, provide coordinated, comprehensive, team-based medical/social/behavioral health support, and monitor disease outcomes of adults living with SCD. The NCSCC will enhance health care service coordination to implement the goals of the 2018 California State Sickle Cell Action Plan and of AB1105. The NCSCC will: 1) establish a network of adult SCD treatment centers with community partners in counties with largest numbers of adult SCD patients; 2) increase the quality of and access to specialty care for adults with SCD in the state; 3) expand the number of healthcare providers trained in providing the standard of care for SCD; 4) Support workforce expansion, among both clinicians and community health workers, to enhance care coordination; 4) conduct outreach to raise awareness of SCD via public education campaigns.
    Characterizing the Complications Associated with Therapeutic Blood Transfusions for Hemoglobinopathies.
    CDC DD19-1903 NCT03207009Sep 30, 2019 - Sep 29, 2024
    Role: Co-Investigator
    Description: This grant builds upon findings from the CDC-RFA-DD14-1406. The project aims to enhance appropriate use and safety of transfusions in hemoglobinopathies through education, surveillance, and the promotion of consensus and evidence-based guidelines. Multi-faceted strategies include: a) identification of patients, families, communities, and providers who will benefit from increased knowledge about therapeutic transfusions for hemoglobinopathies; b) development and dissemination of educational materials to increase understanding of hemoglobinopathies and standardize treatment and management; c) improved coordination of healthcare services; d) increased access to care for individuals with thalassemia or sickle cell disease; e) decreased transfusion-related complications; and f) biological specimen collection for future studies to improve quality of life for patients.
    A Phase II Open-Label, Multicenter Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmodynamics of AG-348 pyruvate kinase (PKR) activator in Adults with Non-Transfusion-Dependent Alpha and beta Thalassemia.
    Agios 348-C-010 NCT03692052Apr 9, 2019 - Nov 28, 2027
    Role: PI
    Description: Primary endpoint is to evaluate the efficacy of treatment with AG-348 in increasing hemoglobin (Hb) concentrations. The secondary endpoints are to evaluate the safety of AG-348 in adult subjects with thalassemia, to determine the effect of AG-348 on markers of hemolysis, erythropoietic activity, and iron metabolism, and to evaluate the pharmacokinetics of AG-348.
    REDS-IV-P (Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric, Domestic Hubs)
    NHLBI/Vitalant 75N92019D00034Apr 1, 2019 - Mar 31, 2024
    Role: Co-PI
    Description: The REDS-IV-P program is a 7-year comprehensive study involving multicenter programs in the US and in Brazil to evaluate the availability and safety of the blood supply through the conduct of epidemiologic and laboratory studies and data analysis assessing the prevalence, incidence, and potential clinical relevance of infectious agents among blood donors and recipients. Implementation of enhanced blood safety measures and policies in blood banking and transfusion medicine policies and practices will increase the safety and effectiveness of blood transfusion therapies for adults, neonates, and children.
    In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses with Alpha Thalassemia Major
    California Institute of Regenerative Medicine (CIRM) CLIN2-09183Aug 1, 2017 - Jul 31, 2024
    Role: Site PI
    Description: This Phase 1, single-site, non-randomized study is designed to take advantage of maternal-fetal tolerance during pregnancy and minimizes risks to fetusesbased on the observation that a fetus remains immune-tolerant to maternal antigens and allows a haplo-fetal transplant from the mother without any exposure to medication. will evaluate the safety and efficacy of in utero hematopoietic cell transplantation (IUHCT) for alpha-thalassemia major (ATM) performed concurrently with in utero transfusion (IUT). Performing IUHCT concurrently with IUT may promote engraftment of maternal hematopoietic cells in utero and lead to a cure for ATM before birth, avoiding lifelong transfusions and the toxicity of a bone marrow transplant.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial. Trials. 2023 Aug 17; 24(1):538. Rees CA, Brousseau DC, Cohen DM, Villella A, Dampier C, Brown K, Campbell A, Chumpitazi CE, Airewele G, Chang T, Denton C, Ellison A, Thompson A, Ahmad F, Bakshi N, Coleman KD, Leibovich S, Leake D, Hatabah D, Wilkinson H, Robinson M, Casper TC, Vichinsky E, Morris CR, SCD Arginine Study Group and PECARN. PMID: 37587492; PMCID: PMC10433602.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    2. The Clinical Phenotypes of Alpha Thalassemia. Hematol Oncol Clin North Am. 2023 04; 37(2):327-339. Lal A, Vichinsky E. PMID: 36907606.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia. Hematol Oncol Clin North Am. 2023 04; 37(2):393-411. Sayani FA, Singer ST, Carlberg KT, Vichinsky EP. PMID: 36907611.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia. J Pediatr Hematol Oncol. 2023 05 01; 45(4):174-180. Paulukonis ST, Snyder A, Smeltzer MP, Sutaria AN, Hurden I, Latta K, Chennuri S, Vichinsky E, Reeves SL. PMID: 37083273; PMCID: PMC10249598.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    5. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease. Exp Biol Med (Maywood). 2023 05; 248(10):897-907. Vissa M, Larkin SK, Vichinsky EP, Kuypers FA, Soupene E. PMID: 36941786; PMCID: PMC10484191.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    6. The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry. Blood Adv. 2023 01 24; 7(2):269-279. Schwab ME, Lianoglou BR, Gano D, Gonzalez Velez J, Allen IE, Arvon R, Baschat A, Bianchi DW, Bitanga M, Bourguignon A, Brown RN, Chen B, Chien M, Davis-Nelson S, de Laat MWM, Ekwattanakit S, Gollin Y, Hirata G, Jelin A, Jolley J, Meyer P, Miller J, Norton ME, Ogasawara KK, Panchalee T, Schindewolf E, Shaw SW, Stumbaugh T, Thompson AA, Towner D, Tsai PS, Viprakasit V, Volanakis E, Zhang L, Vichinsky E, MacKenzie TC. PMID: 36306387; PMCID: PMC9860434.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Development of a Thalassemia International Prognostic Scoring System (TIPSS). Blood Cells Mol Dis. 2023 03; 99:102710. Vitrano A, Musallam KM, Meloni A, Karimi M, Daar S, Ricchi P, Costantini S, Vlachaki E, Di Marco V, El-Beshlawy A, Hajipour M, Ansari SH, Filosa A, Ceci A, Singer ST, Naserullah ZA, Pepe A, Cademartiri F, Pollina SA, Scondotto S, Dardanoni G, Bonifazi F, Sankaran VG, Vichinsky E, Taher AT, Maggio A, International Working Group on Thalassemia (IWG-THAL). PMID: 36463683.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study. Lancet. 2022 08 13; 400(10351):493-501. Kuo KHM, Layton DM, Lal A, Al-Samkari H, Bhatia J, Kosinski PA, Tong B, Lynch M, Uhlig K, Vichinsky EP. PMID: 35964609.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    9. The effects of glutamine supplementation on markers of apoptosis and autophagy in sickle cell disease peripheral blood mononuclear cells. Complement Ther Med. 2022 Nov; 70:102856. Walter PB, Hohman LS, Rokeby A, Lum JJ, Hagar R, Lavrisha L, Saulys A, Kuypers FA, Vichinsky E, Morris CR. PMID: 35843474.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    10. Transitioning Adolescents With Sickle Cell Disease From Pediatric to Adult Care: Results From a New Survey of Health Care Professionals. J Pediatr Hematol Oncol. 2022 10 01; 44(7):e999-e1005. Shah NR, Treadwell MJ, Vichinsky E. PMID: 35700397.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Implications for the metabolic fate of oral glutamine supplementation within plasma and erythrocytes of patients with sickle cell disease: A pharmacokinetics study. Complement Ther Med. 2022 Mar; 64:102803. Morris CR, Kuypers FA, Hagar R, Larkin S, Lavrisha L, Saulys A, Vichinsky EP, Suh JH. PMID: 35032556.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    12. Consensus statement for the perinatal management of patients with α thalassemia major. Blood Adv. 2021 12 28; 5(24):5636-5639. MacKenzie TC, Amid A, Angastiniotis M, Butler C, Gilbert S, Gonzalez J, Keller RL, Kharbanda S, Kirby-Allen M, Koenig BA, Kyono W, Lal A, Lianoglou BR, Norton ME, Ogasawara KK, Panchalee T, Rosner M, Schwab M, Thompson A, Waye JS, Vichinsky E. PMID: 34749399; PMCID: PMC8714716.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia. Am J Hematol. 2022 02 01; 97(2):E78-E80. Musallam KM, Vitrano A, Meloni A, Pollina SA, Karimi M, El-Beshlawy A, Hajipour M, Di Marco V, Ansari SH, Filosa A, Ricchi P, Ceci A, Daar S, Vlachaki E, Singer ST, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Bonifazi F, Sankaran VG, Vichinsky E, Taher AT, Maggio A, International Working Group on Thalassemia (IWG-THAL). PMID: 34862982.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres. Br J Haematol. 2022 01; 196(2):380-389. Chapin J, Cohen AR, Neufeld EJ, Vichinsky E, Giardina PJ, Boudreaux J, Le BC, Kenney K, Trimble S, Thompson AA. PMID: 34775608.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    15. Anterior Pituitary Volume in Patients with Transfusion Dependent Anemias: Volumetric Approaches and Relation to Pituitary MRI‑R2. Clin Neuroradiol. 2022 Mar; 32(1):259-267. Berliner C, Wang ZJ, Singer ST, Grosse R, McDonough RV, Padua E, Yuan Q, Weyhmiller M, James E, Vichinsky E, Adam G, Yamamura J, Bannas P, Fischer R, Schoennagel BP. PMID: 34709410; PMCID: PMC8894216.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia. Br J Haematol. 2022 01; 196(2):414-423. Musallam KM, Vitrano A, Meloni A, Addario Pollina S, Di Marco V, Hussain Ansari S, Filosa A, Ricchi P, Ceci A, Daar S, Vlachaki E, Singer ST, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Karimi M, El-Beshlawy A, Hajipour M, Bonifazi F, Vichinsky E, Taher AT, Sankaran VG, Maggio A, International Working Group on Thalassemia (IWG-THAL). PMID: 34697800.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    17. Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia Haematologica. 2021 09 01; 106(9):2489-2492. Musallam KM, Vitrano A, Meloni A, Pollina SA, Karimi M, El-Beshlawy A, Hajipour M, Di Marco V, Ansari SH, Filosa A, Ricchi P, Ceci A, Daar S, Vlachaki E, Singer ST, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Bonifazi F, Sankaran VG, Vichinsky E, Taher AT, Maggio A. PMID: 33882642; PMCID: PMC8409024.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    18. The transfusion management of beta thalassemia in the United States. Transfusion. 2021 10; 61(10):3027-3039. Lal A, Wong T, Keel S, Pagano M, Chung J, Kamdar A, Rao L, Ikeda A, Puthenveetil G, Shah S, Yu J, Vichinsky E. PMID: 34453453; PMCID: PMC9292563.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    19. Time to rethink haemoglobin threshold guidelines in sickle cell disease. Br J Haematol. 2021 11; 195(4):518-522. Ballas SK, Kuypers FA, Gordeuk VR, Hankins JS, Thompson AA, Vichinsky E. PMID: 34131897; PMCID: PMC9292304.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Pituitary iron and factors predictive of fertility status in transfusion dependent thalassemia. Haematologica. 2021 06 01; 106(6):1740-1744. Singer ST, Fischer R, Allen I, Lal A, Vichinsky E, Yuan Q, Wang ZJ. PMID: 33121232; PMCID: PMC8168491.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation. Bone Marrow Transplant. 2021 09; 56(9):2221-2230. Friedman D, Dozor AJ, Milner J, D'Souza M, Talano JA, Moore TB, Shenoy S, Shi Q, Walters MC, Vichinsky E, Parsons SK, Braniecki S, Moorthy CR, Ayello J, Flower A, Morris E, Mahanti H, Fabricatore S, Klejmont L, van de Ven C, Baxter-Lowe LA, Cairo MS. PMID: 33958740; PMCID: PMC8416746.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Haematol. 2021 May; 8(5):e323-e333. Howard J, Ataga KI, Brown RC, Achebe M, Nduba V, El-Beshlawy A, Hassab H, Agodoa I, Tonda M, Gray S, Lehrer-Graiwer J, Vichinsky E. PMID: 33838113.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    23. Voxelotor for the treatment of sickle cell disease. Expert Rev Hematol. 2021 03; 14(3):253-262. Vissa M, Vichinsky E. PMID: 33602029.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Iron Deficiency: Implications Before Anemia. Pediatr Rev. 2021 01; 42(1):11-20. Tong S, Vichinsky E. PMID: 33386301.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. A complication risk score to evaluate clinical severity of thalassaemia syndromes. Br J Haematol. 2021 02; 192(3):626-633. Vitrano A, Meloni A, Addario Pollina W, Karimi M, El-Beshlawy A, Hajipour M, Di Marco V, Hussain Ansari S, Filosa A, Ricchi P, Ceci A, Daar S, Titi Singer S, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Bonifazi F, Vichinsky E, Maggio A. PMID: 33216983.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA Netw Open. 2020 07 01; 3(7):e2010874. Abrams DI, Couey P, Dixit N, Sagi V, Hagar W, Vichinsky E, Kelly ME, Connett JE, Gupta K. PMID: 32678452; PMCID: PMC7368173.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    27. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020 04 28; 4(8):1554-1588. DeBaun MR, Jordan LC, King AA, Schatz J, Vichinsky E, Fox CK, McKinstry RC, Telfer P, Kraut MA, Daraz L, Kirkham FJ, Murad MH. PMID: 32298430; PMCID: PMC7189278.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    28. Influence of sickle cell disease on susceptibility to HIV infection. PLoS One. 2020; 15(4):e0218880. Kelly S, Jacobs ES, Stone M, Keating SM, Lee TH, Chafets D, Heitman J, Dimapasoc M, Operskalski E, Hagar W, Vichinsky E, Busch MP, Norris PJ, Custer B, Recipient Epidemiology and Donor Evaluation Study (REDS-III). PMID: 32267841; PMCID: PMC7141606.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    29. Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2019 09; 16(9):e17-e32. Ruhl AP, Sadreameli SC, Allen JL, Bennett DP, Campbell AD, Coates TD, Diallo DA, Field JJ, Fiorino EK, Gladwin MT, Glassberg JA, Gordeuk VR, Graham LM, Greenough A, Howard J, Kato GJ, Knight-Madden J, Kopp BT, Koumbourlis AC, Lanzkron SM, Liem RI, Machado RF, Mehari A, Morris CR, Ogunlesi FO, Rosen CL, Smith-Whitley K, Tauber D, Terry N, Thein SL, Vichinsky E, Weir NA, Cohen RT, Klings ES. PMID: 31469310; PMCID: PMC6812163.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    30. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Lancet Neurol. 2019 07; 18(7):631-642. Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmiec T, Büchner B, Steele HE, Horvath R, Chinnery PF, Basu A, Küpper C, Neuhofer C, Kálmán B, Dušek P, Yapici Z, Wilson I, Zhao F, Zibordi F, Nardocci N, Aguilar C, Hayflick SJ, Spino M, Blamire AM, Hogarth P, Vichinsky E. PMID: 31202468.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    31. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519. Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J, HOPE Trial Investigators. PMID: 31199090.
      View in: PubMed   Mentions: 191     Fields:    Translation:HumansCellsCTClinical Trials
    32. Vincristine-induced anemia in hereditary spherocytosis. Exp Biol Med (Maywood). 2019 07; 244(10):850-854. Michlitsch J, Larkin S, Vichinsky E, Kuypers FA. PMID: 31161774; PMCID: PMC6643194.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Evaluation of Mandible Fractures in Patients With Sickle Cell Anemia-A Nationwide Study. J Oral Maxillofac Surg. 2019 Jul; 77(7):1418-1422. Akbari M, Patel R, Carrao V, Hagar W, Vichinsky E, Chuang SK. PMID: 30707980.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Transfusion practices and complications in thalassemia. Transfusion. 2018 12; 58(12):2826-2835. Lal A, Wong TE, Andrews J, Balasa VV, Chung JH, Forester CM, Ikeda AK, Keel SB, Pagano MB, Puthenveetil G, Shah SJ, Yu JC, Vichinsky EP. PMID: 30260477.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    35. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. N Engl J Med. 2018 Jul 19; 379(3):226-235. Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP, Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. PMID: 30021096.
      View in: PubMed   Mentions: 171     Fields:    Translation:HumansCTClinical Trials
    36. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia. N Engl J Med. 2018 04 19; 378(16):1479-1493. Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarré C, Beuzard Y, Chrétien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M. PMID: 29669226.
      View in: PubMed   Mentions: 254     Fields:    Translation:HumansCellsCTClinical Trials
    37. Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States. Pediatr Blood Cancer. 2018 07; 65(7):e27067. Vichinsky E, Cohen A, Thompson AA, Giardina PJ, Lal A, Paley C, Cheng WY, McCormick N, Sasane M, Qiu Y, Kwiatkowski JL. PMID: 29637688.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    38. Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia. Hematol Oncol Clin North Am. 2018 04; 32(2):297-315. Carlberg KT, Singer ST, Vichinsky EP. PMID: 29458733.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    39. Sickle cell disease. Nat Rev Dis Primers. 2018 03 15; 4:18010. Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP. PMID: 29542687.
      View in: PubMed   Mentions: 381     Fields:    Translation:HumansPHPublic Health
    40. Dietary nonheme iron is equally bioavailable from ferritin or ferrous sulfate in thalassemia intermedia. Pediatr Hematol Oncol. 2017 Nov; 34(8):455-467. Khurana M, Fung EB, Vichinsky EP, Theil EC. PMID: 29232169.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Chronic organ failure in adult sickle cell disease. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):435-439. Vichinsky E. PMID: 29222290; PMCID: PMC6142529.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    42. Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors. Blood Cells Mol Dis. 2018 05; 70:66-77. Serjeant GR, Vichinsky E. PMID: 28689691.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    43. Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience. Pediatr Hematol Oncol. 2017 Mar; 34(2):100-106. Winstead M, Sun PP, Martin K, Earl J, Neumayr L, Hoppe C, Vichinsky E. PMID: 28532265.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    44. Lifespan care in SCD: Whom to transition, the patients or the health care system? Am J Hematol. 2017 Jun; 92(6):487-489. Minniti CP, Vichinsky E. PMID: 28211097.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    45. Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial. Br J Haematol. 2017 05; 177(4):620-629. Hoppe C, Jacob E, Styles L, Kuypers F, Larkin S, Vichinsky E. PMID: 28369718; PMCID: PMC5435522.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    46. Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST). Pediatr Blood Cancer. 2017 Sep; 64(9). Vichinsky E, El-Beshlawy A, Al Zoebie A, Kamdem A, Koussa S, Chotsampancharoen T, Bruederle A, Gilotti G, Han J, Elalfy M. PMID: 28296163.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    47. NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease. PLoS One. 2017; 12(2):e0171067. Field JJ, Majerus E, Ataga KI, Vichinsky EP, Schaub R, Mashal R, Nathan DG. PMID: 28152086; PMCID: PMC5289534.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    48. Emergency department utilization by Californians with sickle cell disease, 2005-2014. Pediatr Blood Cancer. 2017 06; 64(6). Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM. PMID: 28000344; PMCID: PMC5403550.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    49. Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature. Prenat Diagn. 2016 Dec; 36(13):1242-1249. Kreger EM, Singer ST, Witt RG, Sweeters N, Lianoglou B, Lal A, Mackenzie TC, Vichinsky E. PMID: 27862048.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    50. Stroke recurrence in adult sickle cell patients: it is time for action! Transfusion. 2016 05; 56(5):1001-4. Neumayr L, Vichinsky E. PMID: 27167352.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    51. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management. Curr Med Res Opin. 2016; 32(1):191-204. Vichinsky E. PMID: 26479125.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    52. Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axis. Am J Hematol. 2015 Sep; 90(9):E190-2. Singer ST, Killilea D, Suh JH, Wang ZJ, Yuan Q, Ivani K, Evans P, Vichinsky E, Fischer R, Smith JF. PMID: 26044409; PMCID: PMC4676944.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    53. Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia. Br J Haematol. 2015 Jun; 169(6):887-98. Morris CR, Kim HY, Klings ES, Wood J, Porter JB, Trachtenberg F, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, Hassell K, Taher A, Neufeld EJ, Thompson AA, Larkin S, Suh JH, Vichinsky EP, Kuypers FA, Thalassemia Clinical Research Network. PMID: 25907665; PMCID: PMC4452408.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    54. Is the medical home for adult patients with sickle cell disease a reality or an illusion? Hemoglobin. 2015; 39(2):130-3. Ballas SK, Vichinsky EP. PMID: 25806421.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    55. In utero hematopoietic cell transplantation for hemoglobinopathies. Front Pharmacol. 2014; 5:278. Derderian SC, Jeanty C, Walters MC, Vichinsky E, MacKenzie TC. PMID: 25628564; PMCID: PMC4290536.
      View in: PubMed   Mentions: 9  
    56. Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients. Br J Haematol. 2014 Dec; 167(5):692-6. Porter JB, Walter PB, Neumayr LD, Evans P, Bansal S, Garbowski M, Weyhmiller MG, Harmatz PR, Wood JC, Miller JL, Byrnes C, Weiss G, Seifert M, Grosse R, Grabowski D, Schmidt A, Fischer R, Nielsen P, Niemeyer C, Vichinsky E. PMID: 25209728; PMCID: PMC4577015.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    57. Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH). Pediatr Blood Cancer. 2014 Dec; 61(12):2271-6. Paulukonis ST, Harris WT, Coates TD, Neumayr L, Treadwell M, Vichinsky E, Feuchtbaum LB. PMID: 25176145.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    58. Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease. Hematology/Oncology Clinics of North America. 2014; 155-414. Vichinsky, Elliott P., ed. View Publication.
    59. Relationship among chelator adherence, change in chelators, and quality of life in thalassemia. Qual Life Res. 2014 Oct; 23(8):2277-88. Trachtenberg FL, Gerstenberger E, Xu Y, Mednick L, Sobota A, Ware H, Thompson AA, Neufeld EJ, Yamashita R, Thalassemia Clinical Research Network. PMID: 24682717; PMCID: PMC4315322.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    60. Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy. Ann Hematol. 2014 Jul; 93(7):1139-48. Singer ST, Kuypers F, Fineman J, Gildengorin G, Larkin S, Sweeters N, Rosenfeld H, Kurio G, Higa A, Jeng M, Huang J, Vichinsky EP. PMID: 24577514; PMCID: PMC4467727.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    61. Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology. 2014 Mar 11; 82(10):835-41. Mackin RS, Insel P, Truran D, Vichinsky EP, Neumayr LD, Armstrong FD, Gold JI, Kesler K, Brewer J, Weiner MW, Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group. PMID: 24523480; PMCID: PMC3959758.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    62. Response to "efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up " Haematologica 2014;99(2):e17-18. Haematologica. 2014 Feb; 99(2):e19. Klings ES, Vichinsky EP, Morris CR. PMID: 24497564; PMCID: PMC3912978.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Emerging therapy in hemoglobinopathies: lessons from the past and optimism for the future. Hematol Oncol Clin North Am. 2014 Apr; 28(2):xiii-xviii. Vichinsky EP. PMID: 24589274.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major. Br J Haematol. 2014 Feb; 164(3):431-7. Klaassen RJ, Barrowman N, Merelles-Pulcini M, Vichinsky EP, Sweeters N, Kirby-Allen M, Neufeld EJ, Kwiatkowski JL, Wu J, Vickars L, Blanchette VS, Forgie M, Yamashita R, Wong-Rieger D, Young NL. PMID: 24180641.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    65. Pain over time and its effects on life in thalassemia. Am J Hematol. 2013 Nov; 88(11):939-43. Oliveros O, Trachtenberg F, Haines D, Gerstenberger E, Martin M, Carson S, Green S, Calamaras D, Hess P, Yamashita R, Vichinsky E, Thalassemia Clinical Research Network. PMID: 23918696; PMCID: PMC3872488.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    66. Renal medullary carcinoma in an adolescent with sickle cell anemia. Pediatr Blood Cancer. 2014 Mar; 61(3):567. Marsh A, Golden C, Hoppe C, Quirolo K, Vichinsky E. PMID: 24108577.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    67. Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea. Am J Hematol. 2013 Dec; 88(12):1068-73. Vichinsky E, Torres M, Minniti CP, Barrette S, Habr D, Zhang Y, Files B, study CICL670A2201 investigators. PMID: 23946212.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    68. Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2013 Oct; 98(4):960-71. Fung EB, Kwiatkowski JL, Huang JN, Gildengorin G, King JC, Vichinsky EP. PMID: 23945720; PMCID: PMC3778866.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    69. Treatment of classic pantothenate kinase-associated neurodegeneration with deferiprone and intrathecal baclofen. Am J Phys Med Rehabil. 2013 Aug; 92(8):728-33. Pratini NR, Sweeters N, Vichinsky E, Neufeld JA. PMID: 23370589; PMCID: PMC3707939.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    70. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion. 2014 Apr; 54(4):972-81; quiz 971. Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, Boudreaux J, Neufeld EJ, Kenney K, Grant A, Thompson AA, CDC Thalassemia Investigators. PMID: 23889533; PMCID: PMC4410835.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansPHPublic Health
    71. Pregnancy outcomes in women with thalassemia in North America and the United Kingdom. Am J Hematol. 2013 Sep; 88(9):771-3. Thompson AA, Kim HY, Singer ST, Vichinsky E, Eile J, Yamashita R, Giardina PJ, Olivieri N, Parmar N, Trachtenberg F, Neufeld EJ, Kwiatkowski JL, Thalassemia Clinical Research Network. PMID: 23757266; PMCID: PMC4106126.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    72. Non-transfusion-dependent thalassemias. Haematologica. 2013 Jun; 98(6):833-44. Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA. PMID: 23729725; PMCID: PMC3669437.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    73. Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone. J Cardiovasc Magn Reson. 2013 May 20; 15:38. Porter JB, Wood J, Olivieri N, Vichinsky EP, Taher A, Neufeld E, Giardina P, Thompson A, Moore B, Evans P, Kim HY, Macklin EA, Trachtenberg F. PMID: 23688265; PMCID: PMC3669105.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    74. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica. 2013 Sep; 98(9):1375-82. Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP. PMID: 23645695; PMCID: PMC3762093.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    75. Clinical manifestations of α-thalassemia. Cold Spring Harb Perspect Med. 2013 May 01; 3(5):a011742. Vichinsky EP. PMID: 23543077; PMCID: PMC3633183.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic Health
    76. The palatability and tolerability of deferasirox taken with different beverages or foods. Pediatr Blood Cancer. 2013 Sep; 60(9):1507-12. Goldberg SL, Giardina PJ, Chirnomas D, Esposito J, Paley C, Vichinsky E. PMID: 23637051.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    77. Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica. 2013 Sep; 98(9):1359-67. Morris CR, Kim HY, Wood J, Porter JB, Klings ES, Trachtenberg FL, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, Singer ST, Taher A, Neufeld EJ, Thompson AA, Sachdev V, Larkin S, Suh JH, Kuypers FA, Vichinsky EP, Thalassemia Clinical Research Network. PMID: 23585527; PMCID: PMC3762091.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    78. Application of multiplex ligation-dependent probe amplification to screen for β-globin cluster deletions: detection of two novel deletions in a multi ethnic population. Hemoglobin. 2013; 37(3):241-56. Cui J, Azimi M, Baysdorfer C, Vichinsky EP, Hoppe CC. PMID: 23577918.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    79. Human T cell lymphotropic virus type 1 infection among U.S. thalassemia patients. AIDS Res Hum Retroviruses. 2013 Jul; 29(7):1006-9. Switzer WM, Shankar A, Trimble SR, Thompson AA, Giardina PJ, Cohen AR, Coates TD, Vichinsky E, Neufeld EJ, Boudreaux JM, Heneine W. PMID: 23409829; PMCID: PMC5810841.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    80. Pain in thalassaemia: the effects of age on pain frequency and severity. Br J Haematol. 2013 Mar; 160(5):680-7. Haines D, Martin M, Carson S, Oliveros O, Green S, Coates T, Eile J, Schilling L, Dinu B, Mendoza T, Gerstenberger E, Trachtenberg F, Vichinsky E, Thalassemia Clinical Research Network. PMID: 23278768.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    81. Increased leucocyte apoptosis in transfused β-thalassaemia patients. Br J Haematol. 2013 Feb; 160(3):399-403. Walter PB, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Coates T, Giardina PJ, Grady RW, Vichinsky E, Olivieri N, Trachtenberg F, Alberti D, Fung E, Ames B, Higa A, Harmatz P, Thalassemia Clinical Research Network. PMID: 23216540; PMCID: PMC4597914.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    82. Combined chelation therapy with deferasirox and deferoxamine in thalassemia. Blood Cells Mol Dis. 2013 Feb; 50(2):99-104. Lal A, Porter J, Sweeters N, Ng V, Evans P, Neumayr L, Kurio G, Harmatz P, Vichinsky E. PMID: 23151373; PMCID: PMC3592978.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    83. A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2012 Nov; 87(11):1017-21. Kutlar A, Ataga K, Reid M, Vichinsky EP, Neumayr L, Blair-Britt L, Labotka R, Glass J, Keefer JR, Wargin WA, Berenson R, Perrine SP. PMID: 22887019; PMCID: PMC3904792.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsCTClinical Trials
    84. The effect of whole body vibration therapy on bone density in patients with thalassemia: a pilot study. Am J Hematol. 2012 Oct; 87(10):E76-9. Fung EB, Gariepy CA, Sawyer AJ, Higa A, Vichinsky EP. PMID: 22886910; PMCID: PMC3845963.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    85. Inadequate dietary intake in patients with thalassemia. J Acad Nutr Diet. 2012 Jul; 112(7):980-90. Fung EB, Xu Y, Trachtenberg F, Odame I, Kwiatkowski JL, Neufeld EJ, Thompson AA, Boudreaux J, Quinn CT, Vichinsky EP, Thalassemia Clinical Research Network. PMID: 22551675; PMCID: PMC3419338.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    86. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions. Transfusion. 2012 Dec; 52(12):2671-6. Wahl SK, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E. PMID: 22519830.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    87. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am J Hematol. 2012 May; 87(5):536-9. Kutlar A, Ataga KI, McMahon L, Howard J, Galacteros F, Hagar W, Vichinsky E, Cheung AT, Matsui N, Embury SH. PMID: 22488107.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCellsCTClinical Trials
    88. Advances in the treatment of alpha-thalassemia. Blood Rev. 2012 Apr; 26 Suppl 1:S31-4. Vichinsky E. PMID: 22631041.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    89. Identification of three novel Hb F variants: Hb F-Hayward [Gγ1(NA1)Gly→Asp, GGT>GAT], Hb F-Chori-I [AγT16(A13)Gly→Asp, GGC>GAC] and Hb F-Chori-II [AγI29(B11)Gly→Glu, GGA>GAA]. Hemoglobin. 2012; 36(3):305-9. Cui J, Baysdorfer C, Azimi M, Vichinsky EP, Hoppe CC. PMID: 22384921.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    90. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012 May 17; 119(20):4587-96. DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. PMID: 22354000; PMCID: PMC3367871.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    91. British Journal of Haematology. Safety of deferasirox in sickle cell disease patients with co-existing liver impairment – response to Sinakos et al. 2012; 157(4):506–507. Vichinsky E. View Publication.
    92. Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort. Blood. 2012 Mar 22; 119(12):2746-53. Kwiatkowski JL, Kim HY, Thompson AA, Quinn CT, Mueller BU, Odame I, Giardina PJ, Vichinsky EP, Boudreaux JM, Cohen AR, Porter JB, Coates T, Olivieri NF, Neufeld EJ, Thalassemia Clinical Research Network. PMID: 22279056; PMCID: PMC3327453.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    93. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells. Immunohematology. 2012; 28(1):20-3. Vichinsky EP. PMID: 22646146.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    94. Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine. Hematology Am Soc Hematol Educ Program. 2012; 2012:271-5. Vichinsky E. PMID: 23233591.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    95. Hb E/beta-thalassaemia: a common & clinically diverse disorder. Indian J Med Res. 2011 Oct; 134:522-31. Olivieri NF, Pakbaz Z, Vichinsky E. PMID: 22089616; PMCID: PMC3237252.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    96. Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. Blood. 2011 Oct 06; 118(14):3794-802. Morris CR, Kim HY, Trachtenberg F, Wood J, Quinn CT, Sweeters N, Kwiatkowski JL, Thompson AA, Giardina PJ, Boudreaux J, Olivieri NF, Porter JB, Neufeld EJ, Vichinsky EP, Thalassemia Clinical Research Network. PMID: 21772051; PMCID: PMC3193260.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    97. Reproductive capacity in iron overloaded women with thalassemia major. Blood. 2011 Sep 08; 118(10):2878-81. Singer ST, Vichinsky EP, Gildengorin G, van Disseldorp J, Rosen M, Cedars MI. PMID: 21757620; PMCID: PMC3172803.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    98. A pilot study of subcutaneous decitabine in β-thalassemia intermedia. Blood. 2011 Sep 08; 118(10):2708-11. Olivieri NF, Saunthararajah Y, Thayalasuthan V, Kwiatkowski J, Ware RE, Kuypers FA, Kim HY, Trachtenberg FL, Vichinsky EP, Thalassemia Clinical Research Network. PMID: 21700776; PMCID: PMC3172790.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    99. Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. Br J Haematol. 2011 Aug; 154(3):387-97. Vichinsky E, Bernaudin F, Forni GL, Gardner R, Hassell K, Heeney MM, Inusa B, Kutlar A, Lane P, Mathias L, Porter J, Tebbi C, Wilson F, Griffel L, Deng W, Giannone V, Coates T. PMID: 21592110; PMCID: PMC3170481.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    100. Iron chelation adherence to deferoxamine and deferasirox in thalassemia. Am J Hematol. 2011 May; 86(5):433-6. Trachtenberg F, Vichinsky E, Haines D, Pakbaz Z, Mednick L, Sobota A, Kwiatkowski J, Thompson AA, Porter J, Coates T, Giardina PJ, Olivieri N, Yamashita R, Neufeld EJ, Thalassemia Clinical Research Network. PMID: 21523808; PMCID: PMC4599708.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    101. Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. Br J Haematol. 2011 Jul; 154(2):281-4. Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E. PMID: 21496003.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    102. A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol. 2011 Jun; 153(5):655-63. Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles L. PMID: 21477202; PMCID: PMC3601917.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    103. Characterization of low bone mass in young patients with thalassemia by DXA, pQCT and markers of bone turnover. Bone. 2011 Jun 01; 48(6):1305-12. Fung EB, Vichinsky EP, Kwiatkowski JL, Huang J, Bachrach LK, Sawyer AJ, Zemel BS. PMID: 21443975; PMCID: PMC3095710.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    104. The mediating effects of family functioning on psychosocial outcomes in healthy siblings of children with sickle cell disease. Pediatr Blood Cancer. 2011 Dec 01; 57(6):1055-61. Gold JI, Treadwell M, Weissman L, Vichinsky E. PMID: 21360652.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    105. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011 Feb 24; 364(8):710-8. Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP. PMID: 21345100.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    106. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol. 2011 Apr; 153(1):121-8. Thompson AA, Cunningham MJ, Singer ST, Neufeld EJ, Vichinsky E, Yamashita R, Giardina P, Kim HY, Trachtenberg F, Kwiatkowski JL, Thalassemia Clinical Research Network Investigators. PMID: 21323889; PMCID: PMC5728106.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    107. The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial. British Journal of Haematology. 2011; 152(6):771–776. Wang, W., Brugnara, C., Snyder, C., Wynn, L., Rogers, Z., Kalinyak, K., Brown, C., Qureshi, A., Bigelow, C., Neumayr, L., Smith-Whitley, K., Chui, D. H. K., Delahunty, M., Woolson, R., Steinberg, M., Telen, M. and Kesler, K. View Publication.
    108. Novel influenza A (H1N1) viral infection in pediatric patients with sickle-cell disease. Pediatr Blood Cancer. 2011 Jan; 56(1):95-8. Jacobs JE, Quirolo K, Vichinsky E. PMID: 20973097.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    109. A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload. Haematologica. 2011 Apr; 96(4):521-5. Rienhoff HY, Viprakasit V, Tay L, Harmatz P, Vichinsky E, Chirnomas D, Kwiatkowski JL, Tapper A, Kramer W, Porter JB, Neufeld EJ. PMID: 21173101; PMCID: PMC3069228.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    110. HbE/β-thalassemia: basis of marked clinical diversity. Hematol Oncol Clin North Am. 2010 Dec; 24(6):1055-70. Olivieri NF, Pakbaz Z, Vichinsky E. PMID: 21075280.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    111. Chart Card: feasibility of a tool for improving emergency department care in sickle cell disease. J Natl Med Assoc. 2010 Nov; 102(11):1017-23. Neumayr L, Pringle S, Giles S, Quirolo KC, Paulukonis S, Vichinsky EP, Treadwell MJ. PMID: 21141289; PMCID: PMC4950679.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    112. Education and employment status of children and adults with thalassemia in North America. Pediatr Blood Cancer. 2010 Oct; 55(4):678-83. Pakbaz Z, Treadwell M, Kim HY, Trachtenberg F, Parmar N, Kwiatkowski JL, Cunningham MJ, Martin M, Sweeters N, Neufeld EJ, Giardina PJ, Olivieri N, Yamashita RC, Vichinsky E. PMID: 20535817; PMCID: PMC2932798.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    113. Pulmonary hypertension and NO in sickle cell. Blood. 2010 Aug 05; 116(5):852-4. Gladwin MT, Barst RJ, Castro OL, Gordeuk VR, Hillery CA, Kato GJ, Kim-Shapiro DB, Machado R, Morris CR, Steinberg MH, Vichinsky EP. PMID: 20688967; PMCID: PMC2918336.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    114. Pulmonary hypertension in thalassemia. Ann N Y Acad Sci. 2010 Aug; 1202:205-13. Morris CR, Vichinsky EP. PMID: 20712794.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    115. Preface to Cooley's Anemia: Ninth Symposium. Ann N Y Acad Sci. 2010 Aug; 1202:ix-x. Vichinsky EP, Neufeld EJ. PMID: 20712763.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    116. Fertility potential in thalassemia major women: current findings and future diagnostic tools. Ann N Y Acad Sci. 2010 Aug; 1202:226-30. Singer ST, Sweeters N, Vega O, Higa A, Vichinsky E, Cedars M. PMID: 20712797; PMCID: PMC5074539.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    117. Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy. Ann N Y Acad Sci. 2010 Aug; 1202:180-7. Vichinsky E. PMID: 20712791.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    118. Transfusion and chelation practices in sickle cell disease: a regional perspective. Pediatr Hematol Oncol. 2011 Mar; 28(2):124-33. Vichinsky EP, Ohene-Frempong K, Thein SL, Lobo CL, Inati A, Thompson AA, Smith-Whitley K, Kwiatkowski JL, Swerdlow PS, Porter JB, Marks PW. PMID: 20673030.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    119. Approaches to transfusion therapy and iron overload in patients with sickle cell disease: results of an international survey. Pediatr Hematol Oncol. 2011 Feb; 28(1):37-42. Vichinsky EP, Ohene-Frempong K, Transfusion Committee. PMID: 20673029.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    120. Relationship between chronic transfusion therapy and body composition in subjects with thalassemia. J Pediatr. 2010 Oct; 157(4):641-7, 647.e1-2. Fung EB, Xu Y, Kwiatkowski JL, Vogiatzi MG, Neufeld E, Olivieri N, Vichinsky EP, Giardina PJ, Thalassemia Clinical Research Network. PMID: 20547400; PMCID: PMC2936667.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    121. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA. 2010 May 12; 303(18):1823-31. Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, Kasten J, Eggleston B, Kesler K, McMahon L, Orringer EP, Harrington T, Kalinyak K, De Castro LM, Kutlar A, Rutherford CJ, Johnson C, Bessman JD, Jordan LB, Armstrong FD, Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group. PMID: 20460621; PMCID: PMC2892214.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    122. Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy. Pediatr Hematol Oncol. 2010 Mar; 27(2):112-21. James EB, Vreman HJ, Wong RJ, Stevenson DK, Vichinsky E, Schumacher L, Hall JY, Simon J, Golden DW, Harmatz P. PMID: 20201692.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    123. Pulmonary hypertension in hemolytic anemias. F1000 Med Rep. 2010 Feb 11; 2. Wahl S, Vichinsky E. PMID: 20948876; PMCID: PMC2948405.
      View in: PubMed   Mentions: 8  
    124. Hemoglobin Hakkari: an autosomal dominant form of beta thalassemia with inclusion bodies arising from de novo mutation in exon 2 of beta globin gene. Pediatr Blood Cancer. 2010 Feb; 54(2):332-5. Kanathezhath B, Hazard FK, Guo H, Kidd J, Azimi M, Kuypers FA, Vichinsky EP, Lal A. PMID: 19852066.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    125. Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia. Magn Reson Imaging. 2010 Apr; 28(3):363-71. Wang ZJ, Fischer R, Chu Z, Mahoney DH, Mueller BU, Muthupillai R, James EB, Krishnamurthy R, Chung T, Padua E, Vichinsky E, Harmatz P. PMID: 20061110; PMCID: PMC2839041.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    126. Low dose, oral epsilon aminocaproic acid for renal papillary necrosis and massive hemorrhage in hemoglobin SC disease. Pediatr Blood Cancer. 2010 Jan; 54(1):148-50. Gabrovsky A, Aderinto A, Aderinto A, Spevak M, Vichinsky E, Resar LM. PMID: 19785026.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    127. Application of an expanded multiplex genotyping assay for the simultaneous detection of Hemoglobin Constant Spring and common deletional alpha-thalassemia mutations. Int J Lab Hematol. 2010 Aug 01; 32(4):373-80. Kidd JL, Azimi M, Lubin B, Vichinsky E, Hoppe C. PMID: 19919622.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    128. Iron metabolism and iron chelation in sickle cell disease. Acta Haematol. 2009; 122(2-3):174-83. Walter PB, Harmatz P, Vichinsky E. PMID: 19907155.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    129. Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complications. Am J Hematol. 2009 Nov; 84(11):759-61. Singer ST, Kim HY, Olivieri NF, Kwiatkowski JL, Coates TD, Carson S, Neufeld E, Cunningham MJ, Giardina PJ, Mueller BU, Quinn CT, Fung E, Vichinsky E, Thalassemia Clinical Research Network. PMID: 19787795; PMCID: PMC4254706.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    130. Severe sickle cell disease--pathophysiology and therapy. Biol Blood Marrow Transplant. 2010 Jan; 16(1 Suppl):S64-7. Buchanan G, Vichinsky E, Krishnamurti L, Shenoy S. PMID: 19819341; PMCID: PMC2832723.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    131. Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload. Br J Haematol. 2009 Dec; 147(5):752-9. Taher A, Cappellini MD, Vichinsky E, Galanello R, Piga A, Lawniczek T, Clark J, Habr D, Porter JB. PMID: 19764988; PMCID: PMC2779992.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    132. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood. 2009 Nov 19; 114(21):4632-8. Adamkiewicz TV, Abboud MR, Paley C, Olivieri N, Kirby-Allen M, Vichinsky E, Casella JF, Alvarez OA, Barredo JC, Lee MT, Iyer RV, Kutlar A, McKie KM, McKie V, Odo N, Gee B, Kwiatkowski JL, Woods GM, Coates T, Wang W, Adams RJ. PMID: 19721013; PMCID: PMC2780299.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    133. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol. 2009 Sep; 146(5):546-56. Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Fleisher M, Grady RW, Peterson CM, Giardina PJ, Thalassemia Clinical Research Network. PMID: 19604241; PMCID: PMC2798591.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    134. HLA type and risk of alloimmunization in sickle cell disease. Am J Hematol. 2009 Jul; 84(7):462-4. Hoppe C, Klitz W, Vichinsky E, Styles L. PMID: 19484735.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    135. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer. 2009 Apr; 52(4):486-90. Michlitsch J, Azimi M, Hoppe C, Walters MC, Lubin B, Lorey F, Vichinsky E. PMID: 19061217; PMCID: PMC4755934.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansPHPublic Health
    136. Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res. 2009 Mar; 24(3):543-57. Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Lane J, Schneider R, Fleisher M, Grady RW, Peterson CC, Giardina PJ, Thalassemia Clinical Research Network. PMID: 18505376; PMCID: PMC3276604.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    137. Alpha thalassemia major--new mutations, intrauterine management, and outcomes. Hematology Am Soc Hematol Educ Program. 2009; 35-41. Vichinsky EP. PMID: 20008180.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    138. Pulmonary complications of sickle cell disease. N Engl J Med. 2008 Nov 20; 359(21):2254-65. Gladwin MT, Vichinsky E. PMID: 19020327.
      View in: PubMed   Mentions: 150     Fields:    Translation:Humans
    139. Hemoglobinopathies. Curr Mol Med. 2008 Nov; 8(7):591. Vichinsky E, Rodgers GP, Rachmilewitz E. PMID: 18991644.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    140. Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells. Am J Hematol. 2008 Nov; 83(11):842-5. Singer ST, Vichinsky EP, Larkin S, Olivieri N, Sweeters N, Kuypers FA, E/beta Thalassemia Study Group. PMID: 18821710; PMCID: PMC2881160.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    141. Psychosocial and behavioral outcomes in children with sickle cell disease and their healthy siblings. J Behav Med. 2008 Dec; 31(6):506-16. Gold JI, Mahrer NE, Treadwell M, Weissman L, Vichinsky E. PMID: 18784995.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    142. Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. Haematologica. 2008 Aug; 93(8):1247-51. Harmatz P, Jonas MM, Kwiatkowski JL, Wright EC, Fischer R, Vichinsky E, Giardina PJ, Neufeld EJ, Porter J, Olivieri N, Thalassemia Clinical Research Network. PMID: 18556414.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    143. Detection and assessment of stroke in patients with sickle cell disease: neuropsychological functioning and magnetic resonance imaging. Pediatr Hematol Oncol. 2008 Jun; 25(5):409-21. Gold JI, Johnson CB, Treadwell MJ, Hans N, Vichinsky E. PMID: 18569843.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    144. Oral iron chelators and the treatment of iron overload in pediatric patients with chronic anemia. Pediatrics. 2008 Jun; 121(6):1253-6. Vichinsky E. PMID: 18519495.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    145. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. Transfusion. 2008 Sep; 48(9):1971-80. Fung EB, Harmatz PR, Milet M, Balasa V, Ballas SK, Casella JF, Hilliard L, Kutlar A, McClain KL, Olivieri NF, Porter JB, Vichinsky EP, Multi-Center Iron Overload Research Group. PMID: 18513257; PMCID: PMC4613769.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    146. An expanded Transactional Stress and Coping Model for siblings of children with sickle cell disease: family functioning and sibling coping, self-efficacy and perceived social support. Child Care Health Dev. 2008 Jul; 34(4):491-502. Gold JI, Treadwell M, Weissman L, Vichinsky E. PMID: 18485027.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    147. Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica. 2008 Jun; 93(6):817-25. Walter PB, Macklin EA, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Coates T, Giardina PJ, Vichinsky E, Olivieri N, Alberti D, Holland J, Harmatz P, Thalassemia Clinical Research Network. PMID: 18469351.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    148. Clinical application of deferasirox: practical patient management. Am J Hematol. 2008 May; 83(5):398-402. Vichinsky E. PMID: 18058997.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    149. Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial. Acta Haematol. 2008; 119(3):133-41. Vichinsky E, Pakbaz Z, Onyekwere O, Porter J, Swerdlow P, Coates T, Lane P, Files B, Mueller BU, Coïc L, Forni GL, Fischer R, Marks P, Rofail D, Abetz L, Baladi JF. PMID: 18408362.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    150. Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia. Bone. 2008 Jul; 43(1):162-168. Fung EB, Harmatz PR, Milet M, Coates TD, Thompson AA, Ranalli M, Mignaca R, Scher C, Giardina P, Robertson S, Neumayr L, Vichinsky EP, Multi-Center Iron Overload Study Group. PMID: 18430624; PMCID: PMC2500183.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    151. Advances in clinical research in sickle cell disease. Br J Haematol. 2008 May; 141(3):346-56. Hagar W, Vichinsky E. PMID: 18341629.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    152. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatr Blood Cancer. 2008 Feb; 50(2):319-24. Jastaniah W, Harmatz P, Pakbaz Z, Fischer R, Vichinsky E, Walters MC. PMID: 17557314.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    153. Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood. 2008 Apr 15; 111(8):3991-7. Ataga KI, Smith WR, De Castro LM, Swerdlow P, Saunthararajah Y, Castro O, Vichinsky E, Kutlar A, Orringer EP, Rigdon GC, Stocker JW, ICA-17043-05 Investigators. PMID: 18192510.
      View in: PubMed   Mentions: 110     Fields:    Translation:Humans
    154. Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.]. Hemoglobin. 2008; 32(6):601-7. Porter JB, Taher AT, Cappellini MD, Vichinsky EP. PMID: 19065340.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    155. Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Eur J Haematol. 2008 Feb; 80(2):168-76. Porter J, Galanello R, Saglio G, Neufeld EJ, Vichinsky E, Cappellini MD, Olivieri N, Piga A, Cunningham MJ, Soulières D, Gattermann N, Tchernia G, Maertens J, Giardina P, Kwiatkowski J, Quarta G, Jeng M, Forni GL, Stadler M, Cario H, Debusscher L, Della Porta M, Cazzola M, Greenberg P, Alimena G, Rabault B, Gathmann I, Ford JM, Alberti D, Rose C. PMID: 18028431; PMCID: PMC2268958.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    156. Clinical differences between children and adults with pulmonary hypertension and sickle cell disease. Br J Haematol. 2008 Jan; 140(1):104-12. Hagar RW, Michlitsch JG, Gardner J, Vichinsky EP, Morris CR. PMID: 17916102.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    157. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood. 2008 Jan 01; 111(1):402-10. Morris CR, Suh JH, Hagar W, Larkin S, Bland DA, Steinberg MH, Vichinsky EP, Shigenaga M, Ames B, Kuypers FA, Klings ES. PMID: 17848621; PMCID: PMC2200820.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    158. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer. 2007 Sep; 49(3):329-32. Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E. PMID: 17554789.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    159. Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator. Br J Haematol. 2007 Aug; 138(3):374-81. Harmatz P, Grady RW, Dragsten P, Vichinsky E, Giardina P, Madden J, Jeng M, Miller B, Hanson G, Hedlund B. PMID: 17614825.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    160. Iron homeostasis during transfusional iron overload in beta-thalassemia and sickle cell disease: changes in iron regulatory protein, hepcidin, and ferritin expression. Pediatr Hematol Oncol. 2007 Jun; 24(4):237-43. Jenkins ZA, Hagar W, Bowlus CL, Johansson HE, Harmatz P, Vichinsky EP, Theil EC. PMID: 17613866.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    161. Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Clin Ther. 2007 May; 29(5):909-917. Cappellini MD, Bejaoui M, Agaoglu L, Porter J, Coates T, Jeng M, Lai ME, Mangiagli A, Strauss G, Girot R, Watman N, Ferster A, Loggetto S, Abish S, Cario H, Zoumbos N, Vichinsky E, Opitz H, Ressayre-Djaffer C, Abetz L, Rofail D, Baladi JF. PMID: 17697909.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    162. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Am J Hematol. 2007 Apr; 82(4):255-65. Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, Owen W, Olivieri N, Smith-Whitley K, Darbari D, Wang W, Vichinsky E, Multi-Center Study of Iron Overload Research Group. PMID: 17094096.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    163. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol. 2007 Feb; 136(3):501-8. Vichinsky E, Onyekwere O, Porter J, Swerdlow P, Eckman J, Lane P, Files B, Hassell K, Kelly P, Wilson F, Bernaudin F, Forni GL, Okpala I, Ressayre-Djaffer C, Alberti D, Holland J, Marks P, Fung E, Fischer R, Mueller BU, Coates T, Deferasirox in Sickle Cell Investigators. PMID: 17233848; PMCID: PMC1974786.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCTClinical Trials
    164. Caregiving time in sickle cell disease: psychological effects in maternal caregivers. Pediatr Blood Cancer. 2007 Jan; 48(1):64-71. Moskowitz JT, Butensky E, Harmatz P, Vichinsky E, Heyman MB, Acree M, Wrubel J, Wilson L, Folkman S. PMID: 16622841.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    165. Hemoglobin e syndromes. Hematology Am Soc Hematol Educ Program. 2007; 79-83. Vichinsky E. PMID: 18024613.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    166. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am. 2006 Dec; 88(12):2573-82. Neumayr LD, Aguilar C, Earles AN, Jergesen HE, Haberkern CM, Kammen BF, Nancarrow PA, Padua E, Milet M, Stulberg BN, Williams RA, Orringer EP, Graber N, Robertson SM, Vichinsky EP, National Osteonecrosis Trial in Sickle Cell Anemia Study Group. PMID: 17142406.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    167. Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer. 2006 Dec; 47(7):901-6. Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. PMID: 16317761.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    168. Dose-escalation study of ICA-17043 in patients with sickle cell disease. Pharmacotherapy. 2006 Nov; 26(11):1557-64. Ataga KI, Orringer EP, Styles L, Vichinsky EP, Swerdlow P, Davis GA, Desimone PA, Stocker JW. PMID: 17064199.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    169. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol. 2006 Nov; 135(4):574-82. Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, Kalinyak KA, Hudes M, Bhatia S, Vichinsky EP, Multi-Centre Study of Iron Overload Research Group. PMID: 17054676.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    170. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol. 2006 Oct; 135(2):254-63. Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, Harmatz P. PMID: 17010049; PMCID: PMC2185791.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    171. Prevalence of HFE mutations in California newborns. Pediatr Hematol Oncol. 2006 Sep; 23(6):507-16. Hoppe C, Watson RM, Long CM, Lorey F, Robles L, Klitz W, Styles L, Vichinsky E. PMID: 16849282.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    172. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol. 2006 Sep; 81(9):670-5. Singer ST, Kuypers FA, Styles L, Vichinsky EP, Foote D, Rosenfeld H. PMID: 16795058.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    173. Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function. Br J Haematol. 2006 May; 133(4):433-5. Hagar RW, Morris CR, Vichinsky EP. PMID: 16643452.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    174. Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait. J Natl Med Assoc. 2006 May; 98(5):704-10. Treadwell MJ, McClough L, Vichinsky E. PMID: 16749645; PMCID: PMC2569269.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    175. Prevalence of fractures among the Thalassemia syndromes in North America. Bone. 2006 Apr; 38(4):571-5. Vogiatzi MG, Macklin EA, Fung EB, Vichinsky E, Olivieri N, Kwiatkowski J, Cohen A, Neufeld E, Giardina PJ. PMID: 16298178; PMCID: PMC4594870.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    176. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics. 2005 Dec; 116(6):e818-25. Vichinsky EP, MacKlin EA, Waye JS, Lorey F, Olivieri NF. PMID: 16291734.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    177. Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome. Br J Haematol. 2005 Nov; 131(3):378-88. Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP, E/beta Thalassaemia Study Group. PMID: 16225658.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    178. Bone and joint disease in sickle cell disease. Hematol Oncol Clin North Am. 2005 Oct; 19(5):929-41, viii. Aguilar C, Vichinsky E, Neumayr L. PMID: 16214653.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    179. Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Am J Hematol. 2005 Sep; 80(1):70-4. Vichinsky E, Butensky E, Fung E, Hudes M, Theil E, Ferrell L, Williams R, Louie L, Lee PD, Harmatz P. PMID: 16138345.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    180. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005 Jul 06; 294(1):81-90. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM, Gladwin MT. PMID: 15998894; PMCID: PMC2065861.
      View in: PubMed   Mentions: 284     Fields:    Translation:Humans
    181. Clinical evaluation of avascular necrosis in patients with sickle cell disease: Children's Hospital Oakland Hip Evaluation Scale--a modification of the Harris Hip Score. Arch Phys Med Rehabil. 2005 Jul; 86(7):1369-75. Aguilar CM, Neumayr LD, Eggleston BE, Earles AN, Robertson SM, Jergesen HE, Stulberg BN, Vichinsky EP. PMID: 16003666.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    182. Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatr Blood Cancer. 2005 May; 44(5):500-7. Treadwell MJ, Law AW, Sung J, Hackney-Stephens E, Quirolo K, Murray E, Glendenning GA, Vichinsky E. PMID: 15602707.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    183. Measuring chromosome breaks in patients with thalassemia. Ann N Y Acad Sci. 2005; 1054:439-44. Offer T, Bhagat A, Lal A, Atamna W, Singer ST, Vichinsky EP, Kuypers FA, Ames BN. PMID: 16339694.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    184. Utility of Holter electrocardiogram in iron-overloaded hemoglobinopathies. Ann N Y Acad Sci. 2005; 1054:476-80. Qureshi N, Avasarala K, Foote D, Vichinsky EP. PMID: 16339701.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    185. Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci. 2005; 1054:481-5. Morris CR, Kuypers FA, Kato GJ, Lavrisha L, Larkin S, Singer T, Vichinsky EP. PMID: 16339702; PMCID: PMC3217300.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    186. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann N Y Acad Sci. 2005; 1054:457-61. Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, Singer T, Vichinsky EP. PMID: 16339697.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    187. Outcomes of preimplantation genetic diagnosis therapy in treatment of beta-thalassemia: A retrospective analysis. Ann N Y Acad Sci. 2005; 1054:500-3. Qureshi N, Foote D, Walters MC, Singer ST, Quirolo K, Vichinsky EP. PMID: 16339706.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    188. Treatment of hepatitis C virus infection in thalassemia. Ann N Y Acad Sci. 2005; 1054:290-9. Butensky E, Pakbaz Z, Foote D, Walters MC, Vichinsky EP, Harmatz P. PMID: 16339677.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    189. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005; 1054:18-24. Vichinsky EP. PMID: 16339647.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansPHPublic Health
    190. Hemoglobin E-beta-thalassemia: Progress report from the International Study Group. Ann N Y Acad Sci. 2005; 1054:33-9. Premawardhena A, De Silver S, Arambepola M, Olivieri NF, Vichinsky EP, Merson L, Muraco G, Allen A, Fisher C, Peto T, Weatherall DJ. PMID: 16339649.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    191. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. Ann N Y Acad Sci. 2005; 1054:250-6. Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP. PMID: 16339672.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    192. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia. Ann N Y Acad Sci. 2005; 1054:486-91. Pakbaz Z, Fischer R, Treadwell M, Yamashita R, Fung EB, Calvelli L, Quirolo K, Foote D, Harmatz P, Vichinsky EP. PMID: 16339703.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    193. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol. 2005 Jan; 123(1):146-52. Butensky E, Fischer R, Hudes M, Schumacher L, Williams R, Moyer TP, Vichinsky E, Harmatz P. PMID: 15762291.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    194. Hematologic problems in immigrants from Southeast Asia. Hematol Oncol Clin North Am. 2004 Dec; 18(6):1405-22, x. Jeng MR, Vichinsky E. PMID: 15511622.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    195. The new SQUID biosusceptometer at Oakland: first year of experience. Neurol Clin Neurophysiol. 2004 Nov 30; 2004:5. Fung EB, Fischer R, Pakbaz Z, Fagaly RL, Vichinsky E, Starr TN, Ewing T, Paulson DN, Hassenzahl WV, Harmatz P. PMID: 16012600.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    196. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatr Radiol. 2005 Jan; 35(1):66-72. Jones A, Granger S, Brambilla D, Gallagher D, Vichinsky E, Woods G, Berman B, Roach S, Nichols F, Adams RJ. PMID: 15517239.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    197. The role of fetal hemoglobin-enhancing agents in thalassemia. Semin Hematol. 2004 Oct; 41(4 Suppl 6):17-22. Lal A, Vichinsky E. PMID: 15534853.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    198. Thalassemia in Sri Lanka: a progress report. Hum Mol Genet. 2004 Oct 01; 13 Spec No 2:R203-6. Premawardhena A, De Silva S, Arambepola M, Olivieri N, Merson L, Muraco J, Allen A, Fisher C, Peto T, Vichinsky E, Weatherall D. PMID: 15358726.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    199. Pulmonary hypertension in sickle cell disease. N Engl J Med. 2004 Feb 26; 350(9):857-9. Vichinsky EP. PMID: 14985481.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    200. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94. Adams RJ, Brambilla DJ, Granger S, Gallagher D, Vichinsky E, Abboud MR, Pegelow CH, Woods G, Rohde EM, Nichols FT, Jones A, Luden JP, Bowman L, Hagner S, Morales KH, Roach ES, STOP Study. PMID: 14751925.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    201. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004; 14-34. Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. PMID: 15561674.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    202. Managing sickle cell disease. BMJ. 2003 Nov 15; 327(7424):1151-5. Claster S, Vichinsky EP. PMID: 14615343; PMCID: PMC261819.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    203. Gene interactions and stroke risk in children with sickle cell anemia. Blood. 2004 Mar 15; 103(6):2391-6. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L, CSSCD Investigators. PMID: 14615367.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    204. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003 Oct; 143(4):438-44. Adamkiewicz TV, Sarnaik S, Buchanan GR, Iyer RV, Miller ST, Pegelow CH, Rogers ZR, Vichinsky E, Elliott J, Facklam RR, O'Brien KL, Schwartz B, Van Beneden CA, Cannon MJ, Eckman JR, Keyserling H, Sullivan K, Wong WY, Wang WC. PMID: 14571216.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    205. Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease. J Pediatr Hematol Oncol. 2003 Aug; 25(8):629-34. Morris CR, Vichinsky EP, van Warmerdam J, Machado L, Kepka-Lenhart D, Morris SM, Kuypers FA. PMID: 12902916.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    206. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics. 2003 Jul; 112(1 Pt 1):87-95. Neumayr L, Lennette E, Kelly D, Earles A, Embury S, Groncy P, Grossi M, Grover R, McMahon L, Swerdlow P, Waldron P, Vichinsky E. PMID: 12837872.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    207. Deferiprone and hepatic fibrosis. Blood. 2003 Jun 15; 101(12):5089-90; author reply 5090-1. Brittenham GM, Nathan DG, Olivieri NF, Porter JB, Pippard M, Vichinsky EP, Weatherall DJ. PMID: 12788794.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    208. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003 Apr 02; 289(13):1645-51. Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M. PMID: 12672732.
      View in: PubMed   Mentions: 265     Fields:    Translation:HumansCTClinical Trials
    209. Liver ferritin subunit ratios in neonatal hemochromatosis. Pediatr Hematol Oncol. 2003 Apr-May; 20(3):229-35. Hagar W, Vichinsky EP, Theil EC. PMID: 12637219.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    210. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med. 2003 Jul 01; 168(1):63-9. Morris CR, Morris SM, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP. PMID: 12626350.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCTClinical Trials
    211. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. J Pediatr Hematol Oncol. 2003 Jan; 25(1):46-55. Dean D, Neumayr L, Kelly DM, Ballas SK, Kleman K, Robertson S, Iyer RV, Ware RE, Koshy M, Rackoff WR, Pegelow CH, Waldron P, Benjamin L, Vichinsky E, Acute Chest Syndrome Study Group. PMID: 12544773.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    212. Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood. 2003 Apr 01; 101(7):2865-9. Hoppe C, Klitz W, Noble J, Vigil L, Vichinsky E, Styles L. PMID: 12517810.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    213. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002 Apr 15; 99(8):3014-8. Pegelow CH, Macklin EA, Moser FG, Wang WC, Bello JA, Miller ST, Vichinsky EP, DeBaun MR, Guarini L, Zimmerman RA, Younkin DP, Gallagher DM, Kinney TR. PMID: 11929794.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    214. Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool. J Pain Symptom Manage. 2002 Feb; 23(2):114-20. Franck LS, Treadwell M, Jacob E, Vichinsky E. PMID: 11844631.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    215. Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study. J Pediatr. 2002 Feb; 140(2):225-9. Wang WC, Helms RW, Lynn HS, Redding-Lallinger R, Gee BE, Ohene-Frempong K, Smith-Whitley K, Waclawiw MA, Vichinsky EP, Styles LA, Ware RE, Kinney TR. PMID: 11865275.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    216. Using quality improvement strategies to enhance pediatric pain assessment. Int J Qual Health Care. 2002 Feb; 14(1):39-47. Treadwell MJ, Franck LS, Vichinsky E. PMID: 11871628.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    217. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol. 2001 Dec; 58(12):2017-21. Pegelow CH, Wang W, Granger S, Hsu LL, Vichinsky E, Moser FG, Bello J, Zimmerman RA, Adams RJ, Brambilla D, STOP Trial. PMID: 11735775.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    218. A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia. Br J Haematol. 2001 Sep; 114(3):718-20. Hoppe C, Cheng S, Grow M, Silbergleit A, Klitz W, Trachtenberg E, Erlich H, Vichinsky E, Styles L. PMID: 11553004.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    219. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001 Sep; 41(9):1086-92. Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ, Stroke Prevention Trail in Sickle Cell Anemia. PMID: 11552063.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCellsCTClinical Trials
    220. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001 Sep; 139(3):385-90. Miller ST, Macklin EA, Pegelow CH, Kinney TR, Sleeper LA, Bello JA, DeWitt LD, Gallagher DM, Guarini L, Moser FG, Ohene-Frempong K, Sanchez N, Vichinsky EP, Wang WC, Wethers DL, Younkin DP, Zimmerman RA, DeBaun MR, Cooperative Study of Sickle Cell Disease. PMID: 11562618.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    221. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001 Sep; 139(3):391-7. Wang W, Enos L, Gallagher D, Thompson R, Guarini L, Vichinsky E, Wright E, Zimmerman R, Armstrong FD, Cooperative Study of Sickle Cell Disease. PMID: 11562619.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    222. Correlation of abnormal intracranial vessel velocity, measured by transcranial Doppler ultrasonography, with abnormal conjunctival vessel velocity, measured by computer-assisted intravital microscopy, in sickle cell disease. Blood. 2001 Jun 01; 97(11):3401-4. Cheung AT, Harmatz P, Wun T, Chen PC, Larkin EC, Adams RJ, Vichinsky EP. PMID: 11369629.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    223. Nesidioblastosis in sickle cell disease. Pediatr Pathol Mol Med. 2001 Mar-Apr; 20(2):155-65. Culberson DE, Manci EA, Shah AK, Haynes J, Ballas SK, Pegelow C, Vichinsky E. PMID: 12673839.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    224. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 2001; 7(12):665-73. Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR, Roberts IA, Yeager AM, Hsu L, Adamkiewicz T, Kurtzberg J, Vichinsky E, Storer B, Storb R, Sullivan KM, Multicenter Investigation of Bone Marrow Transplantation for Sickle Cell Disease. PMID: 11787529.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCTClinical Trials
    225. Stem cell transplantation for sickle cell disease: can we reduce the toxicity? Pediatr Pathol Mol Med. 2001 Jan-Feb; 20(1):73-86. Fixler J, Vichinsky E, Walters MC. PMID: 12673845.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    226. Universal newborn screening for Hb H disease in California. Genet Test. 2001; 5(2):93-100. Lorey F, Cunningham G, Vichinsky EP, Lubin BH, Witkowska HE, Matsunaga A, Azimi M, Sherwin J, Eastman J, Farina F, Waye JS, Chui DH. PMID: 11551109.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    227. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood. 2000 Nov 15; 96(10):3369-73. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. PMID: 11071629.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCells
    228. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol. 2000 Nov-Dec; 22(6):515-20. Morris CR, Kuypers FA, Larkin S, Vichinsky EP, Styles LA. PMID: 11132219.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    229. Outreach strategies for Southeast Asian communities: experience, practice, and suggestions for approaching Southeast Asian immigrant and refugee communities to provide thalassemia education and trait testing. J Pediatr Hematol Oncol. 2000 Nov-Dec; 22(6):588-92. Choy J, Foote D, Bojanowski J, Yamashita R, Vichinsky E. PMID: 11132235.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    230. Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood. 2000 Nov 01; 96(9):3276-8. Styles LA, Aarsman AJ, Vichinsky EP, Kuypers FA. PMID: 11050014.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    231. Changing outcome of homozygous alpha-thalassemia: cautious optimism. J Pediatr Hematol Oncol. 2000 Nov-Dec; 22(6):539-42. Singer ST, Styles L, Bojanowski J, Quirolo K, Foote D, Vichinsky EP. PMID: 11132224.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    232. Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. Br J Haematol. 2000 Nov; 111(2):498-500. Morris CR, Kuypers FA, Larkin S, Sweeters N, Simon J, Vichinsky EP, Styles LA. PMID: 11122090.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    233. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000 Jul 01; 96(1):76-9. Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E. PMID: 10891433.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    234. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):335-9. Wang WC, Gallagher DM, Pegelow CH, Wright EC, Vichinsky EP, Abboud MR, Moser FG, Adams RJ. PMID: 10959904.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    235. Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):330-4. Hoppe C, Vichinsky E, Quirolo K, van Warmerdam J, Allen K, Styles L. PMID: 10959903.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    236. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000 Jun 22; 342(25):1855-65. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA. PMID: 10861320.
      View in: PubMed   Mentions: 292     Fields:    Translation:Humans
    237. Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. Blood. 2000 Jun 01; 95(11):3562-7. Styles LA, Hoppe C, Klitz W, Vichinsky E, Lubin B, Trachtenberg E. PMID: 10828044.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    238. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood. 2000 Mar 15; 95(6):1918-24. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE, Buchanan GE, Rogers ZR, Dinndorf P, Davies SC, Roberts IA, Dickerhoff R, Yeager AM, Hsu L, Kurtzberg J, Ohene-Frempong K, Bunin N, Bernaudin F, Wong WY, Scott JP, Margolis D, Vichinsky E, Wall DA, Wayne AS, Pegelow C, Redding-Lallinger R, Wiley J, Klemperer M, Mentzer WC, Smith FO, Sullivan KM. PMID: 10706855.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    239. Sickle-cell disease not identified by newborn screening because of prior transfusion. J Pediatr. 2000 Feb; 136(2):248-50. Reed W, Lane PA, Lorey F, Bojanowski J, Glass M, Louie RR, Lubin BH, Vichinsky EP. PMID: 10657834.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    240. Major changes in sickle cell disease. Adv Pediatr. 2000; 47:249-72. Hagar RW, Vichinsky EP. PMID: 10959446.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    241. Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia. Am J Hematol. 1999 Dec; 62(4):221-7. Hoppe C, Vichinsky E, Lewis B, Foote D, Styles L. PMID: 10589077.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    242. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group. Am J Hematol. 1999 Nov; 62(3):129-38. Vichinsky EP, Neumayr LD, Haberkern C, Earles AN, Eckman J, Koshy M, Black DM. PMID: 10539878.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    243. Transfusion practice for patients with sickle cell disease. Curr Opin Hematol. 1999 Nov; 6(6):432-6. Reed WF, Vichinsky EP. PMID: 10546799.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    244. Bone disease in beta-thalassaemia. Lancet. 1999 Sep 11; 354(9182):881-2. Singer ST, Vichinsky EP. PMID: 10489942.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    245. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood. 1999 Sep 01; 94(5):1550-4. Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE. PMID: 10477679.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansCTClinical Trials
    246. Effects of red blood cell transfusion on resting energy expenditure in adolescents with sickle cell anemia. J Pediatr Gastroenterol Nutr. 1999 Aug; 29(2):127-31. Harmatz P, Heyman MB, Cunningham J, Lee PD, Styles L, Quirolo K, Kopp-Hoolihan L, Ghiron J, Hintz RL, Vichinsky E. PMID: 10435647.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    247. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough? Ann Emerg Med. 1999 Jul; 34(1):64-9. Morris C, Vichinsky E, Styles L. PMID: 10381996.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    248. Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. Am J Hematol. 1999 Apr; 60(4):268-72. Reed W, Jagust W, Al-Mateen M, Vichinsky E. PMID: 10203099.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    249. Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. Preoperative Transfusion in Sickle Cell Disease Study Group. J Pediatr Hematol Oncol. 1999 Mar-Apr; 21(2):129-35. Waldron P, Pegelow C, Neumayr L, Haberkern C, Earles A, Wesman R, Vichinsky E. PMID: 10206459.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    250. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics. 1999 Mar; 103(3):640-5. Kinney TR, Sleeper LA, Wang WC, Zimmerman RA, Pegelow CH, Ohene-Frempong K, Wethers DL, Bello JA, Vichinsky EP, Moser FG, Gallagher DM, DeBaun MR, Platt OS, Miller ST. PMID: 10049969.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    251. Deferoxamine treatment during pregnancy: is it harmful? Am J Hematol. 1999 Jan; 60(1):24-6. Singer ST, Vichinsky EP. PMID: 9883802.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    252. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload. J Clin Apher. 1999; 14(3):122-5. Singer ST, Quirolo K, Nishi K, Hackney-Stephens E, Evans C, Vichinsky EP. PMID: 10540366.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    253. Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction. Transfusion. 1998 Nov-Dec; 38(11-12):1041-5. Reed W, Lee TH, Vichinsky EP, Lubin BH, Busch MP. PMID: 9838935.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    254. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 02; 339(1):5-11. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D. PMID: 9647873.
      View in: PubMed   Mentions: 441     Fields:    Translation:HumansCTClinical Trials
    255. The social impact of migration on disease. Cooley's anemia, thalassemia, and new Asian immigrants. Ann N Y Acad Sci. 1998 Jun 30; 850:509-11. Heer N, Choy J, Vichinsky EP. PMID: 9668597.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    256. Outreach strategies for Asian Pacific Island (API) communities. Ann N Y Acad Sci. 1998 Jun 30; 850:514-5. Choy J, Yamashita RC, Foote D, Heer N, Vichinsky EP. PMID: 9705740.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    257. The morbidity of bone disease in thalassemia. Ann N Y Acad Sci. 1998 Jun 30; 850:344-8. Vichinsky EP. PMID: 9668556.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    258. Bone marrow transplant in thalassemia. A role for radiation? Ann N Y Acad Sci. 1998 Jun 30; 850:503-5. Lee YS, Kristovich KM, Ducore JM, Vichinsky E, Crouse VL, Glader BE, Amylon MD. PMID: 9668596.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    259. The hemoglobin E syndromes. Ann N Y Acad Sci. 1998 Jun 30; 850:334-43. Rees DC, Styles L, Vichinsky EP, Clegg JB, Weatherall DJ. PMID: 9668555.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    260. Preliminary report: hydroxyurea produces significant clinical response in thalassemia intermedia. Ann N Y Acad Sci. 1998 Jun 30; 850:461-2. Styles L, Lewis B, Foote D, Cuda L, Vichinsky EP. PMID: 9668584.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    261. Approaches to working with adult thalassemia patients in pediatric settings. Ann N Y Acad Sci. 1998 Jun 30; 850:516-7. Weissman L, Treadwell M, Foote D, Heer N, Vichinsky EP. PMID: 9668599.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    262. Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin. J Pediatr. 1998 May; 132(5):871-3. Fridge JL, Vichinsky EP. PMID: 9602203.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    263. Acute chest syndrome and sickle cell disease. Curr Opin Hematol. 1998 Mar; 5(2):89-92. Golden C, Styles L, Vichinsky E. PMID: 9570700.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    264. Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group. Am J Hematol. 1998 Feb; 57(2):101-8. Neumayr L, Koshy M, Haberkern C, Earles AN, Bellevue R, Hassell K, Miller S, Black D, Vichinsky E. PMID: 9462540.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    265. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb; 19(1):110-29. Adams RJ, McKie VC, Brambilla D, Carl E, Gallagher D, Nichols FT, Roach S, Abboud M, Berman B, Driscoll C, Files B, Hsu L, Hurlet A, Miller S, Olivieri N, Pegelow C, Scher C, Vichinsky E, Wang W, Woods G, Kutlar A, Wright E, Hagner S, Tighe F, Waclawiw MA, et al. PMID: 9492971.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    266. The natural history of sickle cell disease. Curr Opin Pediatr. 1998 Feb; 10(1):49-52. Hoppe C, Styles L, Vichinsky E. PMID: 9529638.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    267. New considerations in the treatment of sickle cell disease. Annu Rev Med. 1998; 49:461-74. Reed W, Vichinsky EP. PMID: 9509275.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    268. Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy. J Pediatr Hematol Oncol. 1998 Jan-Feb; 20(1):26-31. Olivieri NF, Vichinsky EP. PMID: 9482409.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    269. Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study II. J Pediatr Hematol Oncol. 1997 Jul-Aug; 19(4):327-33. Woods GM, Jorgensen JH, Waclawiw MA, Reid C, Wang W, Pegelow CH, Rogers ZR, Iyer RV, Holbrook CT, Kinney TR, Vichinsky E, DeBaun MR, Grossman NJ, Thomas MD, Falletta JM. PMID: 9256832.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    270. Hydroxyurea in children: present and future. Semin Hematol. 1997 Jul; 34(3 Suppl 3):22-9. Vichinsky EP. PMID: 9317198.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    271. Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. J Pediatr. 1997 May; 130(5):695-703. Kelly P, Kurtzberg J, Vichinsky E, Lubin B. PMID: 9152276.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    272. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood. 1997 Apr 01; 89(7):2554-9. Styles LA, Lubin B, Vichinsky E, Lawrence S, Hua M, Test S, Kuypers F. PMID: 9116302.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    273. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997 Mar 01; 89(5):1533-42. Haberkern CM, Neumayr LD, Orringer EP, Earles AN, Robertson SM, Black D, Abboud MR, Koshy M, Idowu O, Vichinsky EP. PMID: 9057634.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    274. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood. 1997 Mar 01; 89(5):1787-92. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. PMID: 9057664.
      View in: PubMed   Mentions: 139     Fields:    Translation:Humans
    275. New therapies and approaches to transfusion in sickle cell disease in children. Curr Opin Pediatr. 1997 Feb; 9(1):41-5. Styles LA, Vichinsky EP. PMID: 9088754.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    276. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med. 1997 Feb; 102(2):171-7. Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, Vichinsky E. PMID: 9217567.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    277. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr. 1996 Dec; 129(6):828-35. Bjornson AB, Falletta JM, Verter JI, Buchanan GR, Miller ST, Pegelow CH, Iyer RV, Johnstone HS, DeBaun MR, Wethers DL, Wang WC, Woods GM, Holbrook CT, Becton DL, Kinney TR, Reaman GH, Kalinyak K, Grossman NJ, Vichinsky E, Reid CD. PMID: 8969724.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    278. Pulmonary complications. Hematol Oncol Clin North Am. 1996 Dec; 10(6):1275-87. Vichinsky E, Styles L. PMID: 8956016.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    279. First report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: splenic regeneration. Blood. 1996 Sep 15; 88(6):1951-3. Claster S, Vichinsky E. PMID: 8822912.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    280. Core decompression in avascular necrosis of the hip in sickle-cell disease. Am J Hematol. 1996 Jun; 52(2):103-7. Styles LA, Vichinsky EP. PMID: 8638629.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    281. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol. 1996 May; 17(5):965-72. Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman RA, Wang WC, Ohene-Frempong K, Schwartz A, Vichinsky EP, Gallagher D, Kinney TR. PMID: 8733975; PMCID: PMC8337529.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    282. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 1996 May; 2(2):100-4. Walters MC, Patience M, Leisenring W, Eckman JR, Buchanan GR, Rogers ZR, Olivieri NE, Vichinsky E, Davies SC, Mentzer WC, Powars D, Scott JP, Bernaudin F, Ohene-Frempong K, Darbyshire PJ, Wayne A, Roberts IA, Dinndorf P, Brandalise S, Sanders JE, Matthews DC, Appelbaum FR, Storb R, Sullivan KM. PMID: 9118298.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    283. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood. 1996 Mar 15; 87(6):2573-8. Styles LA, Schalkwijk CG, Aarsman AJ, Vichinsky EP, Lubin BH, Kuypers FA. PMID: 8630425.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    284. Ototoxicity in hemoglobinopathy patients chelated with desferrioxamine. J Pediatr Hematol Oncol. 1996 Feb; 18(1):42-5. Styles LA, Vichinsky EP. PMID: 8556369.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    285. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program. J Pediatr Hematol Oncol. 1996 Feb; 18(1):36-41. Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B. PMID: 8556368.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    286. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood. 1995 Nov 15; 86(10):3676-84. Koshy M, Weiner SJ, Miller ST, Sleeper LA, Vichinsky E, Brown AK, Khakoo Y, Kinney TR. PMID: 7579333.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    287. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. J Pediatr. 1995 Nov; 127(5):685-90. Falletta JM, Woods GM, Verter JI, Buchanan GR, Pegelow CH, Iyer RV, Miller ST, Holbrook CT, Kinney TR, Vichinsky E, et al. PMID: 7472817.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCellsCTClinical Trials
    288. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995 Jul 27; 333(4):206-13. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M, Ohene-Frempong K, Iyer RV. PMID: 7791837.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCTClinical Trials
    289. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood. 1995 Jul 15; 86(2):776-83. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, Pegelow CH, Vichinsky E. PMID: 7606007.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    290. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9. Pegelow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, Olivieri N, Vichinsky E, Wang W, Brambilla D. PMID: 7776091.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCTClinical Trials
    291. Liver transplantation in a child with sickle cell anemia. Transplantation. 1995 May 27; 59(10):1490-2. Lang T, Berquist WE, So SK, Cox KL, Rich EJ, Vichinsky E, Concepcion W, Esquivel CO. PMID: 7770941.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    292. Chronic pulmonary disorders in sickle cell disease: findings at thin-section CT. Radiology. 1994 Dec; 193(3):807-11. Aquino SL, Gamsu G, Fahy JV, Claster S, Embury SH, Mentzer WC, Vichinsky EP. PMID: 7972829.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    293. Effects of a long-term transfusion regimen on sickle cell-related illnesses. J Pediatr. 1994 Dec; 125(6 Pt 1):909-11. Styles LA, Vichinsky E. PMID: 7996363.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    294. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood. 1994 Jun 01; 83(11):3107-12. Vichinsky E, Williams R, Das M, Earles AN, Lewis N, Adler A, McQuitty J. PMID: 8193347.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    295. New advances in the pathophysiology and management of sickle cell disease. Curr Opin Hematol. 1994 Mar; 1(2):125-35. Shafer FE, Vichinsky E. PMID: 9371271.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    296. A cautionary note regarding hydroxyurea in sickle cell disease. Blood. 1994 Feb 15; 83(4):1124-8. Vichinsky EP, Lubin BH. PMID: 7509209.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    297. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):67-71. Perrine SP, Olivieri NF, Faller DV, Vichinsky EP, Dover GJ, Ginder GD. PMID: 7508690.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    298. Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):27-9. Mentzer WC, Heller S, Pearle PR, Hackney E, Vichinsky E. PMID: 8311169.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    299. Universal screening for hemoglobinopathies using high-performance liquid chromatography: clinical results of 2.2 million screens. Eur J Hum Genet. 1994; 2(4):262-71. Lorey F, Cunningham G, Shafer F, Lubin B, Vichinsky E. PMID: 7704556.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    300. Detection of Hb E/beta-thalassemia versus homozygous EE using high-performance liquid chromatography results from newborns. Biochem Med Metab Biol. 1993 Feb; 49(1):67-73. Lorey FW, Cunningham GC, Vichinsky E, Lubin B, Shafer F, Eastman J. PMID: 7679916.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    301. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med. 1993 Jan 14; 328(2):81-6. Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE, Cai SP, Vichinsky EP, Olivieri NF. PMID: 7677966.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCTClinical Trials
    302. F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study. Blood. 1993 Jan 01; 81(1):9-14. Nagel RL, Vichinsky E, Shah M, Johnson R, Spadacino E, Fabry ME, Mangahas L, Abel R, Stamatoyannopoulos G. PMID: 8417806.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    303. Differentiation of homozygous hemoglobin E from compound heterozygous hemoglobin E-beta O-thalassemia by hemoglobin E mutation analysis. J Pediatr. 1992 May; 120(5):775-9. Johnson JP, Vichinsky E, Hurst D, Camber A, Lubin B, Louie E. PMID: 1374466.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    304. Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-Chori. N Engl J Med. 1991 Oct 17; 325(16):1150-4. Witkowska HE, Lubin BH, Beuzard Y, Baruchel S, Esseltine DW, Vichinsky EP, Kleman KM, Bardakdjian-Michau J, Pinkoski L, Cahn S, et al. PMID: 1891024.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    305. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991 Jul 04; 325(1):11-6. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. PMID: 1710777.
      View in: PubMed   Mentions: 477     Fields:    Translation:Humans
    306. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol. 1991 Jul; 28(3):220-6. Vichinsky EP. PMID: 1887248.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    307. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990 Jun 07; 322(23):1617-21. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. PMID: 2342522.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    308. Vitamin C deficiency in patients with sickle cell anemia. Am J Pediatr Hematol Oncol. 1990; 12(3):262-7. Chiu D, Vichinsky E, Ho SL, Liu T, Lubin BH. PMID: 2240472.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    309. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia. Blood. 1989 Jul; 74(1):454-9. Perrine SP, Miller BA, Faller DV, Cohen RA, Vichinsky EP, Hurst D, Lubin BH, Papayannopoulou T. PMID: 2473801.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    310. Experience with newborn screening using isoelectric focusing. Pediatrics. 1989 May; 83(5 Pt 2):852-4. Kleman KM, Vichinsky E, Lubin BH. PMID: 2717314.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    311. Elevated fasting breath hydrogen and abnormal hydrogen breath tests in children with sickle cell disease: a preliminary report. Am J Clin Nutr. 1989 Apr; 49(4):654-7. Heyman MB, Lande W, Vichinsky E, Mentzer W. PMID: 2929487.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    312. Hematopoietic hormones: from cloning to clinic. Am J Pediatr Hematol Oncol. 1989; 11(3):268-75. Perrine SP, Vichinsky E, Faller DV. PMID: 2675659.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    313. Butyrate analogues modulate globin gene expression in human and ovine erythroid cells. Prog Clin Biol Res. 1989; 316B:341-50. Perrine SP, Miller BA, Papayannopoulou T, Faller DV, Rudolph AM, Vichinsky E, Hurst D, Kan YW. PMID: 2616579.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    314. Newborn screening for sickle cell disease: effect on mortality. Pediatrics. 1988 Jun; 81(6):749-55. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. PMID: 3368274.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansPHPublic Health
    315. Contraceptive use in the chronically ill adolescent female. J Adolesc Health Care. 1988 Jan; 9(1):87. Vichinsky E, McDonald C. PMID: 3335479.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    316. Suggested guidelines for the treatment of children with sickle cell anemia. Hematol Oncol Clin North Am. 1987 Sep; 1(3):483-501. Vichinsky E, Lubin BH. PMID: 3329183.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    317. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986 Jun 19; 314(25):1593-9. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS, et al. PMID: 3086721.
      View in: PubMed   Mentions: 239     Fields:    Translation:HumansCTClinical Trials
    318. Growth retardation in sickle-cell disease treated by nutritional support. Lancet. 1985 Apr 20; 1(8434):903-6. Heyman MB, Vichinsky E, Katz R, Gaffield B, Hurst D, Castillo R, Chiu D, Kleman K, Ammann AJ, Thaler MM, et al. PMID: 2858749.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    319. Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia. J Pediatr. 1984 Aug; 105(2):261-3. Weintrub PS, Schiffman G, Addiego JE, Matthay KK, Vichinsky E, Johnson R, Lubin B, Mentzer WC, Ammann AJ. PMID: 6747758.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    320. Inadequate erythroid response to hypoxia in cystic fibrosis. J Pediatr. 1984 Jul; 105(1):15-21. Vichinsky EP, Pennathur-Das R, Nickerson B, Minor M, Kleman K, Higashino S, Lubin B. PMID: 6737132.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    321. Evidence for the presence of CFU-E with increased in vitro sensitivity to erythropoietin in sickle cell anemia. Blood. 1984 May; 63(5):1168-71. Pennathur-Das R, Alpen E, Vichinsky E, Garcia J, Lubin B. PMID: 6713094.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    322. Evidence for a heterogeneous response to erythropoietin in the CFUE pool of human bone marrow. Exp Hematol. 1984 Jan; 12(1):31-7. Pennathur-Das R, Alpen E, Vichinsky E, Lubin B. PMID: 6583068.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    323. Iron deficiency in health and disease. Adv Pediatr. 1983; 30:281-320. Reeves JD, Vichinsky E, Addiego J, Lubin BH. PMID: 6369941.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    324. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. N Engl J Med. 1982 Feb 04; 306(5):270-4. Embury SH, Dozy AM, Miller J, Davis JR, Kleman KM, Preisler H, Vichinsky E, Lande WN, Lubin BH, Kan YW, Mentzer WC. PMID: 6172710.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    325. Peroxidation, vitamin E, and sickle-cell anemia. Ann N Y Acad Sci. 1982; 393:323-35. Chiu D, Vichinsky E, Yee M, Kleman K, Lubin B. PMID: 6959561.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    326. Multidisciplinary approach to pain management in sickle cell disease. Am J Pediatr Hematol Oncol. 1982; 4(3):328-33. Vichinsky EP, Johnson R, Lubin BH. PMID: 6128939.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    327. The diagnosis of iron deficiency anemia in sickle cell disease. Blood. 1981 Nov; 58(5):963-8. Vichinsky E, Kleman K, Embury S, Lubin B. PMID: 7296005.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    328. Current treatment of sickle cell disease. Curr Probl Pediatr. 1980 Oct; 10(12):1-64. Davis JR, Vichinsky EP, Lubin BH. PMID: 7428420.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    329. Unstable hemoglobins, hemoglobins with altered oxygen affinity, and m-hemoglobins. Pediatr Clin North Am. 1980 May; 27(2):421-8. Vichinsky EP, Lubin BH. PMID: 7383714.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    330. Sickle cell anemia and related hemoglobinopathies. Pediatr Clin North Am. 1980 May; 27(2):429-47. Vichinsky EP, Lubin BH. PMID: 6155657.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    331. Fetal Hb production during acute erythroid expansion. I. Observations in patients with transient erythroblastopenia and post-phlebotomy. Br J Haematol. 1980 Apr; 44(4):535-46. Papayannopoulou T, Vichinsky E, Stamatoyannopoulos G. PMID: 6155136.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    332. Anemia in the newborn period. Pediatr Ann. 1979 Jul; 8(7):416-34. Lubin B, Vichinsky E. PMID: 471553.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    333. Anemia associated with rheumatoid arthritis. J Pediatr. 1979 Apr; 94(4):678. Vichinsky EP. PMID: 430321.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    334. Immune response after splenectomy. Lancet. 1978 Jan 28; 1(8057):178-81. Sullivan JL, Ochs HD, Schiffman G, Hammerschlag MR, Miser J, Vichinsky E, Wedgwood RJ. PMID: 74605.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    335. Preparation and properties of a cell-free system from rat skin that catalyzes sterol biosynthesis. J Lipid Res. 1966 Jul; 7(4):501-10. Gaylor JL, Delwiche CV, Brady DR, Green AJ. PMID: 4290536.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    336. Guidelines for the Management of Non Tranfusion Dependent Thalassemia (NTDT). Thalassemia International Federation, 2013. Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. View Publication.
    Elliott's Networks
    Concepts (983)
    Derived automatically from this person's publications.
    _
    Co-Authors (71)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _